ScholarLens Back to search
2018•PubMedRequires access

[Prospect for chimeric antigen receptor-engineered T cell immunotherapy for solid tumors].

Shengyu Zhou, Yuankai Shi

Open publisher page 0 citations

Abstract

to establish a feasible and effective CART-based solid tumor therapy model. Therefore, we summarized the advances, challenges and possible solutions for CAR T therapy to treat solid tumors, and then prospected in the future clinical treatment.

About this research paper

What this paper is about

to establish a feasible and effective CART-based solid tumor therapy model. Therefore, we summarized the advances, challenges and possible solutions for CAR T therapy to treat solid tumors, and then prospected in the future clinical treatment.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

to establish a feasible and effective CART-based solid tumor therapy model. Therefore, we summarized the advances, challenges and possible solutions for CAR T therapy to treat solid tumors, and then prospected in the future clinical treatment.

Key concepts: Chimeric antigen receptor, Immunotherapy, T cell, Cancer research, Solid tumor, Medicine, Antigen, Cell therapy

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
[Prospect for chimeric antigen receptor-engineered T cell immunotherapy for solid tumors]. — Research Paper | ScholarLens